Research and Markets: Hospital Infection Therapeutics (Antibacterial, Antiviral and Antifungal Drugs) Market - Global Pipeline Analysis 2014-2020

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/g6rsch/hospital) has announced the addition of the "Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering.

Some of the major driving factors for the growth of this market are increasing prevalence of various hospital infections, aging population, increasing healthcare awareness and demand for improved therapeutic drugs. Demand for hospital infection therapeutics will especially rise in low to medium income countries due to the presence of high patient population suffering from different hospital infections, hot and humid environmental conditions, lack of standard healthcare facilities and low social awareness. However, rising multi-drug resistant bacterial strains have rendered available drugs obsolete.

Moreover, increasing infection control and surveillance programs may present a threat to the growth of this market. Huge scope for the development of hospital infection therapeutics in treating range of multi-drug resistant microbes and increased penetration in emerging economies would contribute to the growth of the market in near future.

North America dominates the global hospital infection therapeutics market followed by the European market in 2013. Key factors contributing to the growth of the region are high prevalence of various hospital infections, rising number of multi-drug resistant microbial pathogens, increasing demand for advanced therapeutics, and high ratio of hospitals per thousand of the population. This region also comprises huge geriatric population that are more prone towards different hospital infections due to their lowered immunity levels, hence require use of various antimicrobial therapeutics, which in turn will contribute towards the growth of this market.

Asia-Pacific represents the fastest growing geographic region in the global hospital infection therapeutics market during the forecast period from 2014 to 2020. Key factor responsible for the rapid growth of this market is increasing prevalence of hospital-acquired infections in the region. Increasing healthcare awareness and infrastructure along with increasing purchasing power of the people will add to the growth of this market in the region.

The global hospital infection therapeutics market is segmented as follows:

Hospital Infection Therapeutics Market, by Drug Type

  • Antibacterial Drugs
  • Antiviral Drugs
  • Antifungal Drugs

Hospital Infection Therapeutics Market, by Major Infections

  • Hospital-Acquired Pneumonia
  • Surgical Site Infections
  • Urinary Tract Infections
  • Gastrointestinal Disorders
  • Bloodstream Infections
  • Other Hospital Infections

Companies Mentioned

  • Actavis plc
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cubist Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Sanofi

For more information visit http://www.researchandmarkets.com/research/g6rsch/hospital

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Hospital, Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Hospital, Infectious Diseases